advertisement
11.4 Prostaglandins (74)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980
79246 Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues
El Ameen A
European Journal of Ophthalmology 2018; 0: 1120672118805877
78941 A Long-term Safety Study of Latanoprost in Pediatric Patients With Glaucoma and Ocular Hypertension: A Prospective Cohort Study
Younus M
American Journal of Ophthalmology 2018; 196: 101-111
78523 Tear biomarkers in latanoprost and bimatoprost treated eyes
Reddy S
PLoS ONE 2018; 13: e0201740
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980
78786 Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis
Diaconita V
Journal of Ophthalmology 2018; 2018: 3190684
78817 Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
Takagi Y
Clinical Ophthalmology 2018; 12: 1837-1844
78946 The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy
Seibold LK
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 590-595
78953 Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma
Kim DH
Ophthalmic Epidemiology 2019; 26: 63-71
78821 Experimental Evaluation of Travoprost-Induced Changes in Biomechanical Behavior of Ex-Vivo Rabbit Corneas
Zheng X
Current Eye Research 2018; 0: 1-6
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Aspberg J
Journal of Glaucoma 2018; 27: 976-980
79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Seal JR
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57
78389 Effects of sustained daily latanoprost application on anterior chamber anatomy and physiology in mice
Dutca LM
Scientific reports 2018; 8: 13088
78899 Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma
Matsou A
Expert Opinion on Investigational Drugs 2018; 27: 777-785
79295 Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
Heijl A
Journal of Glaucoma 2018; 27: 976-980
78946 The Diurnal and Nocturnal Effects of Pilocarpine on Intraocular Pressure in Patients Receiving Prostaglandin Analog Monotherapy
Wagner BD
Journal of Ocular Pharmacology and Therapeutics 2018; 34: 590-595
78953 Comparative Effectiveness of Generic Latanoprost Versus Branded Prostaglandin Analogs for Primary Open Angle Glaucoma
Addis VM
Ophthalmic Epidemiology 2019; 26: 63-71
78389 Effects of sustained daily latanoprost application on anterior chamber anatomy and physiology in mice
Rudd D
Scientific reports 2018; 8: 13088
78899 Investigational drugs targeting prostaglandin receptors for the treatment of glaucoma
Anastasopoulos E
Expert Opinion on Investigational Drugs 2018; 27: 777-785
78817 Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review
Santo K
Clinical Ophthalmology 2018; 12: 1837-1844
78821 Experimental Evaluation of Travoprost-Induced Changes in Biomechanical Behavior of Ex-Vivo Rabbit Corneas
Wang Y
Current Eye Research 2018; 0: 1-6
79202 Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Robinson MR
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 50-57
78786 Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis
Quinn M
Journal of Ophthalmology 2018; 2018: 3190684
79246 Objective ocular surface tolerance in patients with glaucoma treated with topical preserved or unpreserved prostaglandin analogues
Vandermeer G
European Journal of Ophthalmology 2018; 0: 1120672118805877
78941 A Long-term Safety Study of Latanoprost in Pediatric Patients With Glaucoma and Ocular Hypertension: A Prospective Cohort Study
Schachar RA
American Journal of Ophthalmology 2018; 196: 101-111